ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 188,49
-0,63%
Dow Jones
39 869,38
-0,10%
DAX
18 738,81
-0,72%
Brent Oil
83,24
0,04%
Bitcoin
65 389,89
0,23%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Ayala Pharmaceuticals Inc (AYLA)

  7. Ayala Pharmaceuticals Inc (AYLA) Actualités

AYLA

Ayala Pharmaceuticals (AYLA)

Ayala Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AYLA
DateHeureSourceTitreSymboleSociété
08/02/202323h17Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AYLAAyala Pharmaceuticals Inc
06/02/202320h50Edgar (US Regulatory)Schedule 13g
(sc 13g/a)		NASDAQ:AYLAAyala Pharmaceuticals Inc
25/01/202322h54Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AYLAAyala Pharmaceuticals Inc
24/01/202316h22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AYLAAyala Pharmaceuticals Inc
24/01/202312h07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/01/202321h52Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/01/202321h44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/01/202321h33Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:AYLAAyala Pharmaceuticals Inc
04/11/202221h38Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:AYLAAyala Pharmaceuticals Inc
03/11/202221h08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AYLAAyala Pharmaceuticals Inc
11/10/202210h46TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
11/10/202210h45TipRanksNoble Financial Reaffirms Their Hold Rating on Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
27/09/202216h11TipRanksAyala Pharma (NASDAQ:AYLA) Bags fast Track Status for Desmoid Tumor CandidateNASDAQ:AYLAAyala Pharmaceuticals Inc
27/09/202214h58Dow Jones NewsAyala Pharmaceuticals Gets Fast-Track Designation for AL102 Cancer TreatmentNASDAQ:AYLAAyala Pharmaceuticals Inc
19/09/202212h25TipRanksH.C. Wainwright Sticks to Their Buy Rating for Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
13/09/202214h05TipRanksAyala Pharmaceuticals (AYLA) Receives a Buy from Noble FinancialNASDAQ:AYLAAyala Pharmaceuticals Inc
17/08/202214h05TipRanksNoble Financial Keeps Their Buy Rating on Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
16/08/202222h40AllPennyStocks.comQ2 Financial Results Send Micro Cap SoaringNASDAQ:AYLAAyala Pharmaceuticals Inc
27/07/202214h25TipRanksNoble Financial Thinks Ayala Pharmaceuticals’ Stock is Going to RecoverNASDAQ:AYLAAyala Pharmaceuticals Inc
26/07/202220h24TipRanksAyala Pharmaceuticals Stock Nearly Triples on Desmoid Tumor Treatment NewsNASDAQ:AYLAAyala Pharmaceuticals Inc
25/07/202223h21Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/05/202212h26TipRanksH.C. Wainwright Reiterates a Buy Rating on Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
17/05/202214h45TipRanksNoble Financial Reaffirms Their Buy Rating on Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
27/04/202222h04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AYLAAyala Pharmaceuticals Inc
30/03/202212h35TipRanksAnalysts Conflicted on These Healthcare Names: Acelrx (ACRX) and Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
28/03/202219h32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AYLAAyala Pharmaceuticals Inc
09/03/202212h24TipRanksH.C. Wainwright Thinks Ayala Pharmaceuticals’ Stock is Going to RecoverNASDAQ:AYLAAyala Pharmaceuticals Inc
04/02/202215h17Edgar (US Regulatory)Schedule 13gNASDAQ:AYLAAyala Pharmaceuticals Inc
17/01/202223h14TipRanksBuy These 2 Small-Cap Stocks to Double Your Investment, Say AnalystsNASDAQ:AYLAAyala Pharmaceuticals Inc
15/11/202114h00GlobeNewswire Inc.Ayala Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:AYLAAyala Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:AYLA

Dernières Valeurs Consultées

BIT
UC3C5T
Unicredit Bank
LSE
AT03
Hsbc Bk.24
USOTC
ARHCF
Alfresa Holdings Corp To... (PK)
BIT
UV4KDF
Unicredit Bank
BIT
UB1C6T
Unicredit Bank
COIN
BTRRRBTC
BTRIPS
BIT
UB9V19
Unicredit Bank
BIT
F39026
Vontobel Financial Produ...
LSE
AF20
Citi Fun 24
BIT
UC6127
Unicredit Bank
COIN
CRBTEUR
Cruisebit
LSE
JAR
Jardine Matheson Holding...
NYSE
DOC
Healthpeak Properties
BIT
E15S
UBS Lux Fnd Sol Bmbrg MS...
BIT
F35417
Vontobel Financial Produ...
COIN
ABLUSD
Airbloc
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés